Request Deal Involvement

Allergan to acquire LifeCell business of Acelity for $2.9bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Debevoise & Plimpton

legal advisors

Debevoise & Plimpton

Guggenheim Partners

financial advisors

Guggenheim Partners

Barclays

financial advisors

Barclays

Simpson Thacher & Bartlett

legal advisors

Simpson Thacher & Bartlett

Goldman Sachs

financial advisors

Goldman Sachs

JP Morgan

financial advisors

JP Morgan

or

Principals

ACELITY (LIFE CELL BUSINESS)

target

ACELITY (LIFE CELL BUSINESS)

ALLERGAN PLC

bidder

ALLERGAN PLC

ACELITY INC

vendor

ACELITY INC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite